The global hemodialysis and peritoneal dialysis market size is expected to reach USD 250.38 billion by 2033, registering a CAGR of 9.84% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing incidence of renal diseases, alongside the noteworthy growth in geriatric population has fueled the market demand for hemodialysis and peritoneal dialysis globally. Moreover, growing funding for the development of new products will provide a lucrative scenario for the market.
Over the recent past, the COVID-19 pandemic has been associated with surges in hospitalization and infection hotspots around the country. The pandemic led to a growth in demand for Renal Replacement Therapy (RRT) globally, owing to higher prevalence of comorbid conditions, such as Chronic Kidney Diseases (CKD), diabetes, and hypertension. The demand for dialysis machines surged significantly during this period. As per a research study published in American Society of Nephrology, the demand for dialysis machines required to manage cases of AKI amplified by 279% over baseline during the spring of 2020 in New York City.
Moreover, the rising prevalence of End-stage Renal Disease (ESRD) is likely to propel the market. For instance, according to USRDS, in 2020, there was an increase of 2.5% of people suffering from ESRD. A total of 130,400 new patients were registered who were treated for ESRD which accounted increase of 14.84% of people suffering from ESRD from 2010-2019.
Request a free sample copy or view report summary: Hemodialysis And Peritoneal Dialysis Market Report
Based on type, in 2025, the hemodialysis segment accounted for the largest market share and is expected to grow at the fastest CAGR over the forecast period.
Based on product, in 2025, the service is dominating the hemodialysis and peritoneal dialysis market. This dominant share is attributed both to the prevalence of ESRD and the increased number of dialysis service providers.
By end use, in 2025, the hospital-based segment is dominating the hemodialysis and peritoneal dialysis market. Segmental dominance is likely to remain strong in the coming years, given the significant availability of highly qualified and experienced healthcare personnel in hospitals.
North America dominated the hemodialysis and peritoneal dialysis industry, with the largest revenue share of 38.10% in 2025. Important industry players, significant government funding for the development of cutting-edge medical equipment, and a fair reimbursement environment all contribute to the region's market expansion.
Grand View Research has segmented the global hemodialysis and peritoneal dialysis market on the basis of type, product, end use, and region:
Hemodialysis And Peritoneal Dialysis Type Outlook (Revenue, USD Million, 2021 - 2033)
Hemodialysis
Conventional hemodialysis
Short daily hemodialysis
Nocturnal hemodialysis
Peritoneal Dialysis
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
Hemodialysis And Peritoneal Dialysis Product Outlook (Revenue, USD Million, 2021 - 2033)
Device
Machine
Dialyzer
Water treatment system
Others
Consumables
Bloodline
Concentrates
Catheters
Others
Service
Hemodialysis And Peritoneal Dialysis End Use Outlook (Revenue, USD Million, 2021 - 2033)
Home-Based
Hospital-Based
Hemodialysis And Peritoneal Dialysis Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Hemodialysis And Peritoneal Dialysis Market
Baxter
B. Braun SE
Fresenius Medical Care AG
Medtronic
Asahi Kasei Medical Co., Ltd.
Nipro Corp.
DaVita (Optum)
BD
Nikkiso Co., Ltd.
Cantel Medical (STERIS plc)
Diaverum (M42)
vivISOL
"The quality of research they have done for us has been excellent..."